Postdoctoral Training Program in Obstetric and Pediatric Pharmacoepidemiology (T32) | Apply Online

Opportunity Summary:

The Postdoctoral Training Program in Obstetric and Pediatric Pharmacoepidemiology (T32) is a National Institutes of Health (NIH) institutional training grant opportunity issued through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). It is designed to support organizations that want to run structured, research-focused postdoctoral training programs that build strong expertise in pharmacoepidemiology as it applies to two populations where medication safety and effectiveness questions are especially complex: children and pregnant women. The announcement emphasizes programs that are creative and innovative, with the broader NICHD goal of ensuring the United States has a well-prepared and diverse biomedical workforce capable of meeting national behavioral, clinical, and translational research needs.

At its core, the FOA is aimed at developing the next generation of academic investigators who can conduct high-quality pharmacoepidemiologic research in obstetrics and pediatrics. Pharmacoepidemiology sits at the intersection of pharmacology, epidemiology, and public health, and it often relies on real-world data sources to study how medications are used, how safe they are, and how well they work across large populations. In pediatric and obstetric settings, many therapies have historically had limited direct clinical trial evidence, and real-world observational research can play a major role in filling evidence gaps, understanding risks and benefits, and informing clinical guidance and policy. The training programs supported by this mechanism are meant to produce investigators who can independently design and lead such studies, using rigorous methods appropriate for vulnerable or understudied populations.

This opportunity uses the NIH T32 mechanism, meaning it is an institutional award made to an eligible organization rather than to an individual trainee. The applicant institution proposes the overall training program structure, mentoring environment, faculty leadership, and the plan for recruiting and supporting postdoctoral trainees. Because it is an institutional training program, the focus is not just on funding research projects, but on building an organized training pipeline with mentorship, didactic instruction, and research experiences that collectively prepare trainees to become productive, independent scientists in pediatric and/or obstetric pharmacoepidemiology. A key theme is workforce development, particularly strengthening the pool of trained scientists and supporting diversity among trainees entering these fields.

The grant is categorized as discretionary and uses the grant funding instrument type, with an activity area associated with health (listed under Health Income Security and Social Services). It is tied to CFDA number 93.865, which corresponds to Child Health and Human Development Extramural Research. There is no cost sharing or matching requirement, which means applicants are not required to provide a formal cost match as a condition of the award (though institutions often contribute resources and infrastructure as part of a competitive training environment).

Eligibility is broad across U.S.-based organizations that can credibly host and administer a postdoctoral research training program. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, and nonprofit organizations (including both 501(c)(3) and non-501(c)(3) nonprofits). The FOA also explicitly includes various mission-driven and minority-serving organization types in its eligibility language, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based or community-based organizations, tribal governments and tribal organizations (with distinctions between federally recognized and other tribal entities), and U.S. territories or possessions. At the same time, the opportunity is limited to domestic applicants: non-U.S. (foreign) institutions are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components as defined by NIH policy are not allowed under this announcement.

From an administrative timeline perspective, the FOA (Funding Opportunity Number PAR-13-112) was posted on February 11, 2013, and the original and current closing date listed is May 25, 2015. It was archived on June 25, 2015, meaning it is no longer active for new submissions under that specific announcement, but it remains a useful reference for understanding how NICHD framed this training priority and what kinds of institutional programs NIH has sought to encourage in this area.

For applicants or interested parties who need the full text of the announcement, the FOA points to the NIH Grants Guide listing (provided via the included link). The contact information included is the NIH Office of Extramural Research (OER) webmaster email addresses, which are intended for technical issues accessing the online announcement or problems linking to the funding notice, rather than scientific program questions.

Overall, this FOA is best understood as a workforce and capacity-building initiative: it funds institutions to create high-quality postdoctoral training environments focused on rigorous pharmacoepidemiologic research in children and pregnant women, with the explicit intent of producing a strong, diverse pipeline of academic investigators prepared to address pressing medication safety, utilization, and outcomes questions in maternal and child health.

Browse more business programs for Training Services

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health Income Security and Social Services

Next opportunity: The Influence of the Microbiome on Preterm Labor and Delivery (R01)

Previous opportunity: A.Seed Bank Study at the Cibola National Wildlife Refuge

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 13 112

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 13 112) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 13 112", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.